The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Employment - Janssen
Leadership - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
Travel, Accommodations, Expenses - Janssen
Other Relationship - Incyte (I)
 
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Lilly; Pfizer
Anti-PD-1 antibody cetrelimab (JNJ-63723283) in patients with advanced cancers: Updated phase I/II study results.
 
Piotr Rutkowski
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Guardant Health; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Research Funding - EMD Serono (Inst); Merck (Inst)
 
Victor Moreno
Consulting or Advisory Role - Puma Biotechnology
Speakers' Bureau - Nanobiotix; Roche
Travel, Accommodations, Expenses - Sanofi/Regeneron
 
Jose Manuel Trigo Perez
No Relationships to Disclose
 
Aitana Calvo
Expert Testimony - Merck; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; SERVIER
 
Dariusz Kowalski
No Relationships to Disclose
 
Diego Cortinovis
No Relationships to Disclose
 
James J. Lee
Consulting or Advisory Role - Abbvie; Incyte; Loxo
Research Funding - Merck
 
George Manikhas
No Relationships to Disclose
 
Elizabeth Ruth Plummer
Honoraria - Bristol-Myers Squibb; Pfizer (I); Roche/Genentech
Consulting or Advisory Role - Astex Pharmaceuticals; Bayer; Biosceptre; Clovis Oncology; Cybrexa Therapeutics; Ellipses Pharma; Karus Therapeutics; MSD Oncology; Novartis; Octimet; Pierre Fabre; Roche/Genentech
Speakers' Bureau - Novartis
Research Funding - AstraZeneca/MedImmune (Inst)
Patents, Royalties, Other Intellectual Property - Named on patent of use of PARP inhibitor rucaparib (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology
 
Michele Maio
Stock and Other Ownership Interests - Theravance
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Roche
 
Paolo Antonio Ascierto
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Idera; Incyte; MedImmune; Merck Serono; Merck Sharp & Dohme; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Sanofi; Sun Pharma; Syndax; Ultimovacs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Vladimir Ivanovich Vladimirov
No Relationships to Disclose
 
Dana Gaffney
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Lilian Y. Li
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Kyounghwa Bae
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
James G. Greger
No Relationships to Disclose
 
Chu Ri Shin
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Hong Xie
No Relationships to Disclose
 
Emiliano Calvo
Employment - HM Hospitales; START
Leadership - START
Stock and Other Ownership Interests - International Cancer Consultants; Oncoart Associated; START
Honoraria - HM Hospitales
Consulting or Advisory Role - Abbvie; Amcure; AstraZeneca; Celgene; EUSA Pharma; Gerson Lehrman Group; Guidepoint Global; Janssen-Cilag; Nanobiotix; Novartis; Pfizer; PsiOxus Therapeutics; Roche/Genentech; Seagen; SERVIER
Speakers' Bureau - Novartis
Research Funding - AstraZeneca; BeiGene; Novartis; START
Travel, Accommodations, Expenses - Roche/Genentech
Other Relationship - Investigational Therapeutics in Oncological Sciences